Literature DB >> 19280101

Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Shulamit Naor1, Zohar Keren, Tomer Bronshtein, Efrat Goren, Marcelle Machluf, Doron Melamed.   

Abstract

Several recent studies proposed a role for innate immunity and inflammation in the pathogenesis of amyotrophic lateral sclerosis (ALS). However, possible links, if any, between disease and adaptive immunity are poorly understood. The present study probed for the role of B cells in ALS disease using the G93A-SOD-1 transgenic mouse model. In agreement with other studies, we show here that autoantibodies are detectable in SOD-1 mice. However, SOD-1 B cells did not express any altered phenotype and exhibited indistinguishable responsiveness to immunogenic stimuli relative to wild-type B cells. This was obtained for B cells isolated before, during and after the onset of ALS-like disease. Finally, to obtain an in vivo conclusion, we generated SOD-1 mice that are deficient of B cells, by crossing SOD-1 mice with Igmu-deficient mice (muMT), where B cell development is blocked at the proB stage. The meteoric assays performed on a rota-rod clearly showed the development of ALS-like disease in SOD-1 mice that are deficient of B cells not differently than in control SOD-1 mice. Our results propose that B lymphocytes do not have a major role in the pathogenesis of ALS-like disease in SOD-1 mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280101     DOI: 10.1007/s00415-009-5097-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  47 in total

1.  Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis.

Authors:  D Schiffer; S Cordera; P Cavalla; A Migheli
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

Review 2.  Current status of SOD1 mutations in familial amyotrophic lateral sclerosis.

Authors:  M Gaudette; M Hirano; T Siddique
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

3.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

4.  Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).

Authors:  Irena Niebroj-Dobosz; Dorota Dziewulska; Piotr Janik
Journal:  Folia Neuropathol       Date:  2006       Impact factor: 2.038

5.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 6.  Inflammatory processes in amyotrophic lateral sclerosis.

Authors:  P L McGeer; E G McGeer
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

7.  Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?

Authors:  Donald R Staines
Journal:  Med Hypotheses       Date:  2007-06-19       Impact factor: 1.538

8.  Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.

Authors:  I Niebroj-Dobosz; P Janik; H Kwieciński
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

9.  MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Jihong Kang; Serge Rivest
Journal:  J Cell Biol       Date:  2007-12-17       Impact factor: 10.539

10.  A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway.

Authors:  Jane Seagal; Efrat Edry; Zohar Keren; Nira Leider; Ofra Benny; Marcelle Machluf; Doron Melamed
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  18 in total

Review 1.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

2.  CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.

Authors:  Maria Chiara Trolese; Alessandro Mariani; Mineko Terao; Massimiliano de Paola; Paola Fabbrizio; Francesca Sironi; Mami Kurosaki; Silvia Bonanno; Silvia Marcuzzo; Pia Bernasconi; Francesca Trojsi; Eleonora Aronica; Caterina Bendotti; Giovanni Nardo
Journal:  EBioMedicine       Date:  2020-11-09       Impact factor: 8.143

Review 3.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

4.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

5.  Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.

Authors:  Satoru Tada; Tatsusada Okuno; Teruhito Yasui; Yuji Nakatsuji; Tomoyuki Sugimoto; Hitoshi Kikutani; Saburo Sakoda
Journal:  J Neuroinflammation       Date:  2011-02-23       Impact factor: 8.322

6.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

Review 7.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

8.  BAFF controls neural cell survival through BAFF receptor.

Authors:  Satoru Tada; Teruhito Yasui; Yuji Nakatsuji; Tatsusada Okuno; Toru Koda; Hideki Mochizuki; Saburo Sakoda; Hitoshi Kikutani
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.

Authors:  Aude Chiot; Sakina Zaïdi; Charlène Iltis; Matthieu Ribon; Félix Berriat; Lorenzo Schiaffino; Ariane Jolly; Pierre de la Grange; Michel Mallat; Delphine Bohl; Stéphanie Millecamps; Danielle Seilhean; Christian S Lobsiger; Séverine Boillée
Journal:  Nat Neurosci       Date:  2020-10-19       Impact factor: 24.884

Review 10.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.